Telehealth Multi-Component Optional Model (MOM) Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-44
SponsorUniversity of Arkansas

About this trial

The aim of this study is to conduct a comparative effectiveness evaluation using a randomized control trail design among diverse women to compare two postpartum care models: 1) Telehealth Multicomponent Optimal Model (Telehealth MOM) and 2) enhanced standard of care (ESoC). This study will address critical gaps in knowledge about how best to deliver comprehensive postpartum care that ensures timely identification and treatment of complications and meets the needs and preferences of diverse patients, including disproportionately-impacted racial groups and rural residents.

Eligibility criteria

Qualifiers

Pregnant women between 16-35 weeks gestation

Age 18-44 years

Ability to speak English, Spanish, or Marshallese

Participants may have either a vaginal birth or cesarean section birth

Disqualifiers

Type 1 diabetes on an insulin pump followed closely by endocrinology

Uncontrolled Type 2 diabetes

End stage renal disease followed closely by nephrology

ICU admission at any point during pregnancy or delivery hospitalization

Trial design

Treatments tested in this trial

  • Telehealth MOM
  • Enhanced Standard of Care

Treatment groups

1,500 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Arkansas

Lead sponsor

Patient-Centered Outcomes Research Institute

Collaborator